IAS - FDA Glove Powder Petition |
IAS - FDA Glove Powder Petition
FDA is proposing to ban most powdered medical gloves.
It has long been known that the glove powder used on surgical and exam gloves can cause a variety of problems, including adhesions.
FDA considered banning these gloves in 1997 but for various reasons declined to do so until now.
The FDA have asked for public comment on this issue which is due by June 20th 2016.
The International Adhesions Society welcomes this ban as a positive step in fighting adhesions, even though the ban is long overdue.
We plan to submit our comments to FDA by 10pm CDT June 19th 2016.
Please read the text of our comments on the next page and signify your approval of its contents in the spaces provided. Please tell your friends about this survey.
Thank you
David Wiseman PhD, MRPharmS
Founder, International Adhesions Society
If you have any questions please contact me at david.wiseman@adhesions.org
PS You can read more about the background to this issue in the formal announcement about this proposal by FDA by clicking on this link. A new window will pop up.
Please Like, Share and Visit our pages:
Background and Disclosure of Conflicts
The IAS is funded mainly by its owner Synechion, Inc. (www.synechion.com), a research and consulting company specializing in the science and business of adhesions. The IAS is not a “not-for-profit” organization. Founded in 1998 and presided over by this author, Synechion’s work is based on an expertise in the field dating back to 1987 and involvement in a large majority of the anti-adhesion products on the market or in development.
The IAS has made a number of achievements including the founding of the world's first clinic for the integrated diagnosis and treatment of adhesions, the characterization of the problems of ARD and CAPPS and the identification of PainShield® MD, a portable wearable therapeutic ultrasound device as a novel and effective analgesic treatment option for patients suffering from pelvic pain and related painful disorders. Accordingly, this author founded KevMed, LLC to market PainShield MD. Sales from this enterprise help support the IAS. Although Synechion, Inc. consults for a number of companies with commercial interests in this subject, this submission has not been solicited by other commercial entities.
The IAS is funded mainly by its owner Synechion, Inc. (www.synechion.com), a research and consulting company specializing in the science and business of adhesions. The IAS is not a “not-for-profit” organization. Founded in 1998 and presided over by this author, Synechion’s work is based on an expertise in the field dating back to 1987 and involvement in a large majority of the anti-adhesion products on the market or in development.
The IAS has made a number of achievements including the founding of the world's first clinic for the integrated diagnosis and treatment of adhesions, the characterization of the problems of ARD and CAPPS and the identification of PainShield® MD, a portable wearable therapeutic ultrasound device as a novel and effective analgesic treatment option for patients suffering from pelvic pain and related painful disorders. Accordingly, this author founded KevMed, LLC to market PainShield MD. Sales from this enterprise help support the IAS. Although Synechion, Inc. consults for a number of companies with commercial interests in this subject, this submission has not been solicited by other commercial entities.